Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionLincoln Capital Corp
Latest Disclosed Ownership6,654 shares
Latest Disclosed Value $ 683,166
Lincoln Capital Corp reports 6.99% decrease in ownership of ABL / Abbott Laboratories

On April 16, 2026 - Lincoln Capital Corp filed a 13F-HR form disclosing ownership of 6,654 shares of Abbott Laboratories (DE:ABL) valued at $591,008 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 7,154 shares of Abbott Laboratories. This represents a change in shares of -6.99% during the quarter. The current value of the position is $500,514 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 6,654 -500 -6.99 683 -23.77 0.2514
2026-01-23 2025-12-31 13F ABBOTT LABS COM 002824100 7,154 0 0.00 896 -6.47 0.3184
2025-10-16 2025-09-30 13F ABBOTT LABS COM 002824100 7,154 0 0.00 958 -1.54 0.3446
2025-07-09 2025-06-30 13F ABBOTT LABS COM 002824100 7,154 0 0.00 973 2.64 0.3736
2025-04-28 2025-03-31 13F ABBOTT LABS COM 002824100 7,154 0 0.00 949 17.18 0.3952
2025-01-21 2024-12-31 13F ABBOTT LABS COM 002824100 7,154 0 0.00 809 -0.74 0.3323
2024-10-23 2024-09-30 13F ABBOTT LABS COM 002824100 7,154 0 0.00 816 9.69 0.3331
2024-07-24 2024-06-30 13F ABBOTT LABS COM 002824100 7,154 -647 -8.29 743 -16.14 0.3183
2024-04-16 2024-03-31 13F ABBOTT LABS COM 002824100 7,801 -1,700 -17.89 887 -15.22 0.3878
2024-01-18 2023-12-31 13F ABBOTT LABS COM 002824100 9,501 -161 -1.67 1,046 11.76 0.5106
2023-11-03 2023-09-30 13F ABBOTT LABS COM 002824100 9,662 0 0.00 936 -11.21 0.5039
2023-07-27 2023-06-30 13F ABBOTT LABS COM 002824100 9,662 0 0.00 1,053 7.67 0.5398
2023-04-21 2023-03-31 13F ABBOTT LABS COM 002824100 9,662 -250 -2.52 978 -10.11 0.5675
2023-01-20 2022-12-31 13F ABBOTT LABS COM 002824100 9,912 0 0.00 1,088 13.45 0.6658
2022-10-24 2022-09-30 13F ABBOTT LABS COM 002824100 9,912 -659 -6.23 959 -16.54 0.6439
2022-07-22 2022-06-30 13F ABBOTT LABS COM 002824100 10,571 -50 -0.47 1,149 -8.59 0.7411
2022-04-19 2022-03-31 13F ABBOTT LABS COM 002824100 10,621 -80 -0.75 1,257 -16.53 0.6557
2022-01-24 2021-12-31 13F ABBOTT LABS COM 002824100 10,701 90 0.85 1,506 20.19 0.7241
2021-10-18 2021-09-30 13F ABBOTT LABS COM 002824100 10,611 92 0.87 1,253 2.79 0.6730
2021-07-22 2021-06-30 13F ABBOTT LABS COM 002824100 10,519 607 6.12 1,219 2.61 0.6953
2021-04-20 2021-03-31 13F ABBOTT LABS COM 002824100 9,912 0 0.00 1,188 9.49 0.7411
2021-02-05 2020-12-31 13F ABBOTT LABS COM 002824100 9,912 0 0.00 1,085 0.56 0.7118
2020-11-04 2020-09-30 13F ABBOTT LABS COM 002824100 9,912 0 0.00 1,079 19.09 0.7894
2020-07-22 2020-06-30 13F ABBOTT LABS COM 002824100 9,912 -500 -4.80 906 10.22 0.7089
2020-04-16 2020-03-31 13F ABBOTT LABS COM 002824100 10,412 -292 -2.73 822 -11.61 0.3682
2020-01-17 2019-12-31 13F ABBOTT LABS COM 002824100 10,704 -1,200 -10.08 930 -6.63 0.6893
2019-11-05 2019-09-30 13F ABBOTT LABS COM 002824100 11,904 0 0.00 996 -0.50 0.8421
2019-07-12 2019-06-30 13F ABBOTT LABS COM 002824100 11,904 -300 -2.46 1,001 2.56 0.8814
2019-04-11 2019-03-31 13F ABBOTT LABS COM 002824100 12,204 0 0.00 976 10.53 0.8830
2019-01-22 2018-12-31 13F ABBOTT LABS COM 002824100 12,204 0 0.00 883 -1.34 0.8143
2018-10-10 2018-09-30 13F ABBOTT LABS COM 002824100 12,204 0 0.00 895 20.30 0.7433
2018-07-26 2018-06-30 13F ABBOTT LABS COM 002824100 12,204 -1,618 -11.71 744 163.83 0.6903
2018-04-12 2018-03-31 13F ABBOTT LABS COM 002824100 13,822 -67,071 -82.91 282 -93.89 0.2620
2018-02-06 2017-12-31 13F ABBOTT LABS COM 002824100 80,893 745 0.93 4,617 7.95 3.9409
2017-10-18 2017-09-30 13F ABBOTT LABS COM 002824100 80,148 12 0.01 4,277 9.81 3.8225
2017-07-25 2017-06-30 13F ABBOTT LABS COM 002824100 80,136 291 0.36 3,895 9.84 3.4444
2017-05-10 2017-03-31 13F ABBOTT LABS COM 002824100 79,845 8,081 11.26 3,546 28.52 3.1679
2017-03-24 2016-12-31 13F ABBOTT LABS COM 002824100 71,764 71,764 2,759 2.6568
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.